{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:34:31Z","timestamp":1790674471071,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)","award":["R21AI099575"],"award-info":[{"award-number":["R21AI099575"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.antiviral.2017.01.021","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:03:53Z","timestamp":1486080233000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses"],"prefix":"10.1016","volume":"141","author":[{"given":"Wenqian","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh Kumar","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Jasim","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan S.J.","family":"Ingrole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-4466","authenticated-orcid":false,"given":"Mayra","family":"Hernandez-Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi P.","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-9698","authenticated-orcid":false,"given":"Lynn","family":"Bimler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0526-3999","authenticated-orcid":false,"given":"Silke","family":"Paust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-2147","authenticated-orcid":false,"given":"E. Bart","family":"Tarbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.01.021_bib1","first-page":"76","article-title":"Avian influenza pandemic: not if, but when","volume":"32","author":"Allen","year":"2006","journal-title":"Pediatr. Nurs."},{"key":"10.1016\/j.antiviral.2017.01.021_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094051","article-title":"Mucosal vaccination with recombinant lactobacillus casei-displayed CTA1-conjugated consensus matrix Protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB\/c mice","volume":"9","author":"Chowdhury","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.01.021_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.021_bib5","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.vaccine.2008.09.038","article-title":"Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies","volume":"26","author":"De Filette","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0301-472X(00)00144-2","article-title":"Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype","volume":"28","author":"Decker","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza a: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib8","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.94.18.9814","article-title":"Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors","volume":"94","author":"Elkon","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.01.021_bib9","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"Gamblin","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.01.021_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20040370","article-title":"A\u00a0contribution of mouse dendritic cell\u2013derived IL-2 for NK cell activation","volume":"200","author":"Granucci","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2017.01.021_bib11","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge","volume":"182","author":"Hamada","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"Holsinger","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.01.021_bib13","doi-asserted-by":"crossref","first-page":"1450004","DOI":"10.1142\/S1793984414500044","article-title":"Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen","volume":"4","author":"Ingrole","year":"2014","journal-title":"Nano Life"},{"key":"10.1016\/j.antiviral.2017.01.021_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1078\/0171-2985-00099","article-title":"Defense against influenza A virus infection: essential role of the chemokine system","volume":"204","author":"Kaufmann","year":"2001","journal-title":"Immunobiology"},{"key":"10.1016\/j.antiviral.2017.01.021_bib15","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1016\/j.vaccine.2014.08.030","article-title":"Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2017.01.021_bib17","doi-asserted-by":"crossref","first-page":"15700","DOI":"10.1021\/jp061667w","article-title":"Turkevich method for gold nanoparticle synthesis revisited","volume":"110","author":"Kimling","year":"2006","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.antiviral.2017.01.021_bib18","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.4049\/jimmunol.1202654","article-title":"Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection","volume":"190","author":"Knuschke","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib19","first-page":"301","article-title":"Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin","volume":"386","author":"Krammer","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.01.021_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2008.03.002","article-title":"The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2)","volume":"31","author":"Lan","year":"2008","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.antiviral.2017.01.021_bib22","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.vaccine.2011.07.136","article-title":"\u03b1-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib23","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.170.9.4665","article-title":"Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways","volume":"170","author":"Miyamoto","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib24","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A\u00a0universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2017.01.021_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","article-title":"Avian influenza virus (H5N1): a threat to human health","volume":"20","author":"Peiris","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2017.01.021_bib27","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.vaccine.2016.01.028","article-title":"Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB\/c mice","volume":"34","author":"Rappazzo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib28","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1128\/JVI.76.21.10717-10723.2002","article-title":"Characterization of the 1918 \u201cSpanish\u201d influenza virus matrix gene segment","volume":"76","author":"Reid","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib30","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib31","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.79.10.6441-6448.2005","article-title":"Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection","volume":"79","author":"Schmitz","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.01.021_bib33","doi-asserted-by":"crossref","first-page":"e0117203","DOI":"10.1371\/journal.pone.0117203","article-title":"Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner","volume":"10","author":"Seth","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.01.021_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2017.01.021_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2017.01.021_bib36","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.vaccine.2015.03.063","article-title":"M2e-immobilized gold nanoparticles as influenza A vaccine: role of soluble M2e and longevity of protection","volume":"33","author":"Tao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/nnm.13.58","article-title":"Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus","volume":"9","author":"Tao","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib38","series-title":"Assembly and Characterization of Biomolecule-gold Nanoparticle Conjugates and Their Use in Intracellular Imaging NanoBiotechnology Protocols","first-page":"85","author":"Tkachenko","year":"2005"},{"key":"10.1016\/j.antiviral.2017.01.021_bib39","doi-asserted-by":"crossref","first-page":"11813","DOI":"10.1128\/JVI.01076-08","article-title":"Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses","volume":"82","author":"Wang","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.01.002","article-title":"Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity","volume":"178","author":"Wang","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.antiviral.2017.01.021_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/CVI.00153-12","article-title":"Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand","volume":"19","author":"Wang","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib42","first-page":"686549","article-title":"Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice","author":"Wang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.antiviral.2017.01.021_bib43","series-title":"Influenza (Seasonal)","author":"WHO","year":"2014"},{"key":"10.1016\/j.antiviral.2017.01.021_bib44","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1016\/j.vaccine.2014.04.062","article-title":"Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes","volume":"32","author":"Wibowo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.021_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.coviro.2013.05.004","article-title":"Virus-induced humoral immunity: on how B cell responses are initiated","volume":"3","author":"Zabel","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib46","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.021_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11259-009-9222-7","article-title":"Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route","volume":"33","author":"Zhang","year":"2009","journal-title":"Vet. Res. Commun."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216304090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T16:48:21Z","timestamp":1601570901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216304090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":47,"alternative-id":["S0166354216304090"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.021","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}